Stockreport

Argo Biopharma Announces First Patient Dosed in Phase 2b Trial of siRNA Therapeutic BW-20829 in Patients with Elevated Lp(a) [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF to developing next-generation siRNA therapies, today announced that the first patient has been dosed in a global Phase 2b clinical trial sponsored by Novartis evaluating [Read more]